Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Net Cash Flow (2018 - 2026)

Viemed Healthcare filings provide 8 years of Net Cash Flow readings, the most recent being $2.4 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 61.6% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.0 million, a 185.92% decrease, with the full-year FY2025 number at -$4.0 million, down 185.92% from a year prior.
  • Net Cash Flow hit $2.4 million in Q4 2025 for Viemed Healthcare, up from -$8.9 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $9.9 million in Q2 2025 to a low of -$13.3 million in Q2 2023.
  • Median Net Cash Flow over the past 5 years was $85000.0 (2021), compared with a mean of -$874000.0.
  • Biggest five-year swings in Net Cash Flow: crashed 13666.67% in 2022 and later soared 1839.73% in 2024.
  • Viemed Healthcare's Net Cash Flow stood at $1.5 million in 2021, then plummeted by 396.17% to -$4.6 million in 2022, then soared by 160.5% to $2.8 million in 2023, then skyrocketed by 124.3% to $6.2 million in 2024, then tumbled by 61.6% to $2.4 million in 2025.
  • The last three reported values for Net Cash Flow were $2.4 million (Q4 2025), -$8.9 million (Q3 2025), and $9.9 million (Q2 2025) per Business Quant data.